ZEVEX INTERNATIONAL INC
10-Q/A, 1996-08-19
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: FIRST TRUST COMBINED SERIES 33, 24F-2NT/A, 1996-08-19
Next: USLICO SERIES FUND/VA/, N-30D, 1996-08-19




                                  
                              FORM 10-Q

                 SECURITIES AND EXCHANGE COMMISSION
                       Washington, D.C.  20549
(Mark One)
[ X ]     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                     SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 1996

                                 OR

[   ]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
              OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from .................to.................

Commission file number 33-19583

                      ZEVEX INTERNATIONAL, INC.
         (Exact name of registrant as specified in charter)

            NEVADA                                      87-0462807
(State or other jurisdiction of            (I.R.S. Employer Identification No.)
 incorporation or organization)

5175 Greenpine Drive, Murray, Utah 
(Address of principal executive offices)
84123
(Zip Code)

                           (801) 264-1001
        (Registrant's telephone number, including area code)

                           Not Applicable
(Former name, former address, and former fiscal year, if changed since
last report)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that
the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.  Yes  [ X ] No

          APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
             PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Indicate by check mark whether the registrant has filed all documents and
reports required to be filed by Sections 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a
plan confirmed by a court.
Yes  [   ]    No  [   ]    Not Applicable  [ X ]
                APPLICABLE ONLY TO CORPORATE ISSUERS
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.  As of August 8, 1996,
the Company had outstanding 1,365,716 shares of common stock, par value
$0.04 per share.


                 Page 1 of 12 Consecutively Numbered Pages








                             PART I

                      FINANCIAL INFORMATION

______________________________________________________________________

       ITEM 1.  FINANCIAL STATEMENTS REQUIRED BY FORM 10-Q
______________________________________________________________________

ZEVEX International, Inc. (the "Company"), files herewith balance
sheets of the Company as of June 30, 1996, and December 31, 1995, and
the related statements of operations and cash flows for the respective
three month and six month periods ended June 30, 1996 and 1995.  In
the opinion of the Companys management, the financial statements
reflect all adjustments, all of which are normal recurring
adjustments, necessary to fairly present the financial condition of
the Company for the interim periods presented.  The financial
statements included in this report on Form 10-Q should be read in
conjunction with the audited financial statements of the Company and
the notes thereto included in the annual report of the Company on Form
10-KSB for the year ended December 31, 1995.






             ZEVEX INTERNATIONAL, INC. & SUBSIDIARY
                          Balance Sheet
                           -Unaudited-
                             ASSETS
                                         Jun 30             Dec 31
                                                              
                                          1996              1995
CURRENT
ASSETS
  Cash in Banks                          630,710           870,333       
  Accounts Receivable                    872,830         1,209,794
  Employee Advances                        2,865             2,835
  Prepaid Taxes                           47,435                 0
  Work-In-Process                      1,241,725           791,960
                                                                  
      Total Current Assets             2,795,565         2,874,922

 OTHER ASSETS
   Net Property and Equipment            634,978           363,771
   Deposits                                3,490             8,682
                                                                  
             Total Other Assets          638,468           372,453
             TOTAL ASSETS              3,434,033         3,247,375

                                
               LIABILITIES & STOCKHOLDERS' EQUITY
LIABILITIES                                                           
   Accounts Payable                      341,265           191,562 
   Other Accrued Expenses                102,349            96,206
   Income Taxes Payable                        0            58,735
                                                                  
          Total Current Liabilities      443,614           346,503 
          Long-Term Debt                       0                 0
          Deferred Taxes                       0                 0
          Total Long-Term Debt                 0                 0

STOCKHOLDERS'EQUITY
          Common Stock 5,000,000 shares
          authorized at $0.04 par value
          issued and outstanding 1,130,716
          shares in 1995 and 1,356,716
          shares in 1996                  54,629            54,629
          Capital in Excess of Par 
          Value                         1,344,833          1,344,833
          Retained Earnings             1,590,957          1,501,410
                 Total Stockholders'
                 Equity                 2,990,419          2,900,872
                 TOTAL LIABILITIES AND                  
                 STOCKHOLDERS'EQUITY    3,434,033          3,247,375







             ZEVEX INTERNATIONAL, INC. & SUBSIDIARY

                     Statement of Operations


                  For Three    For Three     For Six      For Six
                   Months       Months       Months       Months
                    Ended        Ended        Ended        Ended
                   6/30/96      6/30/95      6/30/96      6/30/95
REVENUES                                                           
Sales              1,277,618    1,204,968    2,545,225    2,389,914
Cost of Sales        676,349      674,183    1,389,655    1,357,592
                                                                   
Gross Profit         601,269      530,785    1,155,570    1,032,322
                                                                   
General Expenses
Marketing, G&A       474,435      324,124      831,653      614,933
Research and Devel.  131,586      149,058      245,814      280,491
                                                                   
Operating Income     (4,752)       57,603       78,103      136,898
Other Income          14,642        9,234       27,726       18,645
                                                                   
Provision for Taxes  (3,669)     (13,515)     (16,282)     (21,696)
                                                                   
Net Income (Loss)      6,221       53,322       89,547      133,847
                                                                   
Income Per Share       .0046        .0393         0656        .1076
                                                                   
                                                                   
Weighted Average Shares                                                     
Outstanding        1,365,716    1,356,716    1,365,716    1,243,662









                ZEVEX INTERNATIONAL, INC. & SUBSIDIARY
                                
                     Statement of Cash Flows
                                
            For the three months ended June 30, 1996
                        and June 30, 1995

                                              Jun 30    Jun 30
                                               1996      1995
Cash Flows from Operating Activities:                          
                                                               
Net income (loss)                              89,547   133,847
                                                               
Noncash revenue and expense adjustments:                       
   Depreciation                                99,340    72,498
                                                               
Change in assets and liability accounts:                       
  (Increase) decrease in accounts receivable  336,934 (114,129)
  (Increase) decrease in work-in-process    (449,765)  (63,970)
  (Increase) decrease in deposits               5,192   (9,000)
  (Increase) decrease prepaid expenses       (47,435)    11,724
  Increase (decrease) in accounts payable     149,703    19,086
  Increase (decrease) in accrued expenses       6,143     (367)
  Increase  (decrease) in  provision  
  for taxes                                   (58,735)   21,696
                                                               
Net Cash flows used for                                        
   operating activities                       130,924    71,385
                                                               
Cash flows from investing activities:                          
   Purchase of equipment and tooling         (370,547)  (44,202)
                                                               
Net increase (decrease) in cash              (239,623)    27,183
                                                               
Cash at beginning of period                    870,333   864,332
                                                               
Cash at end of period                          630,710   891,515








            ZEVEX INTERNATIONAL, INC. AND SUBSIDIARY
                                
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                
                          June 30, 1996
                                
                                
1. Summary of Significant Accounting Policies

A. Business Information

     The Company was incorporated under the laws of the State of
     Nevada on December 30, 1987.  The Company was originally
     incorporated as Downey Industries, Inc. and changed its name
     to ZEVEX International, Inc. on August 15, 1988.

B. Principles of Consolidation

     The consolidated financial statements include the accounts of
     ZEVEX, International, Inc. (Company) and its wholly-owned
     subsidiary ZEVEX, Inc.  All significant inter-company balances
     and transactions have been eliminated in the consolidation.
     
C. Machinery and Equipment

     Machinery and equipment are stated at cost less accumulated
     depreciation.  Depreciation is provided over expected useful
     lives of five or seven years on accelerated methods, which
     provide for more depreciation expense in the early years of the
     estimated life of the asset.
     
     Major replacements which extend the useful lives of equipment are
     capitalized and depreciated over the remaining useful life.
     Normal maintenance and repair items are charged to costs and
     expenses incurred.
     
     Upon retirement or disposal of property, plant or equipment, the
     costs and related accumulated depreciation amounts are
     eliminated, and any gain or loss is included in operation in the
     year of disposition.
     
Notes to the financial statements - continued

D. Work In Process

     Work in process is stated at the lower of cost (first-in, first-
     out method) or market value.

E. Bad Debts

     The Company accounts for bad debts using the direct write off
     method.  Accounts are written off when deemed uncollectible.
     
F. Net Income Per Share

     The computation of net income per share of common stock is
     computed  by dividing net income for the period by the weighted
     average number of shares outstanding during the period.  Common
     stock equivalents which dilute earnings per share are not taken
     into consideration in the calculation because they have no
     material impact.

2. Business Combination

On August 11, 1988, the Company acquired the outstanding stock of
ZEVEX, Inc., a manufacturer and producer of acoustic and electronic
equipment for special applications, in exchange for 600,000 shares of
its common stock.  This business combination has been accounted for in
a manner similar to a pooling-of-interests.

Notes to the financial statements - continued

3. Income Taxes

Provision for income taxes is made, at Federal and State statutory
rates, based on earnings reported in the financial statements for the
amount of income taxes payable currently, less any prepayment
deposits.  The provision for income taxes at June 30, 1996 and June
30, 1995 consists of the following:
                                             1996          1995

Federal income taxes                       $  11,033     $  13,919
State income taxes                             5,249         7,777
Provision for income tax                   $  16,282     $  21,696
                                           ==========    ==========

4.Major Customers

The Company distributes its products directly and is not dependent
upon any single customer.  However, sales to three customers for the
six months ending June 30, 1996, each represented 10% or more of total
sales.








______________________________________________________________________

        ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF
          FINANCIAL CONDITION AND RESULTS OF OPERATIONS
______________________________________________________________________

Results of Operations

The Company's sales increased to $1,277,618 in the second quarter 1996
from $1,204,968 in the second quarter 1995, and $2,545,225 for the
first six months of 1996, from $2,389,914 for the first six months of
1995, an increase of approximately 6% for the three months ending June
1996, and an increase of 5% for the six months ending June 1996.
During the first six months of 1996, 65% of total revenues resulted
from sales to three customers, all of whom were major customers in
1995.  Since the Company's products are sold to OEMs as components for
incorporation into products manufactured by them, demand for the
Company's products is affected by the demand for the final products
manufactured by the OEMs, which is beyond the control of the Company,
and no assurances can be given that orders from any customer will
increase or remain at current levels or that they will not decline.

The Company's gross profit as a percentage of sales was 47% in the
second quarter 1996, as compared to 44% in the second quarter 1995,
and 45% for the six months ending June 1996 compared to 43% for the
six months ending June 1995.  Management attributes the increase to
the product mix that was delivered during the second quarter of 1996.

Selling, general and administrative expenses for the quarter ended
June 30, 1996 increased $150,311, from $324,124 in the second quarter
of 1995 to $474,435 in the second quarter of 1996.  Management
attributes the increase in these expenses to increased sales effort,
including travel, and legal costs related to the introduction and
marketing trials of the new Enteralite(Trademark) ambulatory enteral
feeding pump, and increased expenses related to employee insurance and
tax costs.  The Company believes that general and administrative
expenses will remain constant for the remainder of 1996.

Research and development expenses vary from quarter to quarter
depending on the number and nature of pending research and development
projects and their various stages of completion.  During the second
quarter of 1996, research and development expenses were $131,586
compared to $149,058 during the second quarter of 1995, and $245,814
for the first six months of 1996, compared to 280,491 for the first
six months of 1995.  Expenses incurred during the first six months
were for the continued development of several proprietary products and
new applications of the company's ultrasound technology.  Management
believes investing in research and development will serve the
company's future well, and will continue these expenses at the current
rate for at least the next several quarters.

Net income decreased to $6,221, or 0.5% of net sales, in the
second quarter of 1996, from $53,322 in the second quarter of
1995.  Net income of $89,547, or 3.5% of net sales, for the first
six months of 1996 decreased from a net income of $133,847 in the
first six months of 1995.  The decreases in net income during
1996 as compared to 1995 are principally due to increased
selling, general and administrative expenses for the current
year.

As of June 30, 1996 the Company's backlog of customer orders was
$2,726,000, as compared to $3,243,000 on June 30, 1995.  Management
estimates that approximately 90% of the backlog will ship before
December 31, 1996.

Liquidity and Capital Resources

During the quarter ending June 30, 1996, and the six months ending
June 30 1996, the Company produced $6,221 in net income and $89,547 in
net income respectively from operating activities.  Cash decreased by
$239,623 for the six months ending June 30, 1996.  During the quarter
ending June 30, 1995, and the six months ending June 30 1995, the
Company had net incomes of $53,322 and $133,847 respectively from
operating activities. Net cash increased by $27,183 for the six months
ending June 30, 1995, as the Company funded an increase in accounts
receivable and inventories of work in progress for future sale.

The Company's purchases of new research, production, test equipment
and tooling was $181,074 for the second quarter of 1996, and $370,547
for the first six months of 1996.

The Company's working capital at June 30, 1996, was $2,351,951 as
compared to $2,423,087 at June 30, 1995.  The decrease is primarily
attributed to income from operations.  The portion of working capital
represented by cash at such dates was $630,710 and $891,515
respectively.  The Company utilizes substantial portions of its cash
from time to time to fund its operations.







                             PART II
          OTHER INFORMATION NOT APPLICABLE AT THIS TIME

Item 1.  Legal Proceedings
Item 2.  Changes in Securities
Item 3.  Defaults upon Senior Securities
Item 4.  Submission of Matters to a Vote of Security Holders
Item 5.  Other Information
Item 6.  Exhibits and Reports on Form 8-K










______________________________________________________________________

                           SIGNATURES
______________________________________________________________________

Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the Registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.


ZEVEX INTERNATIONAL, INC.


Dated:  May 10, 1996                  By   /s/ Dean G. Constantine
Dean G. Constantine, President


                                      By   /s/ Phillip L. Mcstotts
                                        Phillip L. McStotts, Secretary
                                         (Principal Financial Officer)


<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               JUN-30-1996
<CASH>                                         630,710
<SECURITIES>                                         0
<RECEIVABLES>                                  923,130
<ALLOWANCES>                                         0
<INVENTORY>                                  1,241,725
<CURRENT-ASSETS>                             2,795,565
<PP&E>                                       1,194,532
<DEPRECIATION>                                 559,554
<TOTAL-ASSETS>                               3,434,033
<CURRENT-LIABILITIES>                          443,614
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        54,629
<OTHER-SE>                                   2,935,790
<TOTAL-LIABILITY-AND-EQUITY>                 3,434,033
<SALES>                                      2,545,225
<TOTAL-REVENUES>                             2,545,225
<CGS>                                        1,389,655
<TOTAL-COSTS>                                1,389,655
<OTHER-EXPENSES>                             1,077,467
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                105,829
<INCOME-TAX>                                    16,282
<INCOME-CONTINUING>                             89,547
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    89,547
<EPS-PRIMARY>                                     .066
<EPS-DILUTED>                                     .066
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission